Mylan Gets OK for Generic of Pfizer Allergy Drug

Drug maker Mylansaid Friday that it will immediately start shipping a generic version of Pfizer'sallergy drug Zyrtec after receiving final U.S. regulatory approval.

The U.S. Food and Drug Administration granted Mylan approval of its abbreviated new drug applications for 5 and 10 milligram tablets of Cetirizine Hydrochloride tablets, the company said in a statement.

The tablets are a generic version of Pfizer's Zyrtec, which had U.S. sales of about $1.4 billion for the 12 months ended Sept. 30, Mylan said.

Zyrtec, an antihistamine, treats indoor and outdoor allergy symptoms in adults and children as well as itching due to chronic hives.